Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
OBIO on Nasdaq
Shares outstanding
56,338,036
Price per share
$4.31
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
22,919,413
Total reported value
$56,168,029
% of total 13F portfolios
0%
Share change
+4,786,648
Value change
+$11,822,203
Number of holders
51
Price from insider filings
$4.31
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 15% -29% $22,011,067 8,306,063 0% RTW Investments, LP 04 Aug 2025
Medtronic plc 15% $16,374,276 5,868,916 Medtronic plc 31 Dec 2024
PERCEPTIVE ADVISORS LLC 10% $14,085,110 5,679,480 Perceptive Advisors LLC 30 Sep 2025
Tasso Partners, LLC 5.5% $7,684,508 3,098,592 Dana Lorenzo 15 Nov 2025
BlackRock, Inc. 3.7% $3,991,656 1,430,701 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 51 institutional investors reported holding 22,919,413 shares of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO). This represents 41% of the company’s total 56,338,036 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) together control 40% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RTW INVESTMENTS, LP 15% 8,306,063 +0% 0.25% $20,599,036
PERCEPTIVE ADVISORS LLC 9.4% 5,292,556 +15% 0.38% $13,125,539
VANGUARD GROUP INC 2.6% 1,481,875 +28% 0% $3,675,050
Alyeska Investment Group, L.P. 2.4% 1,365,482 0.01% $3,386,395
Pathstone Holdings, LLC 1.8% 1,006,018 0.01% $2,494,924
Affinity Asset Advisors, LLC 1.3% 727,272 0.17% $1,803,635
BlackRock, Inc. 1.2% 664,333 -2.5% 0% $1,647,546
Knoll Capital Management, LLC 0.81% 455,128 0% 0.23% $421,163
PRICE T ROWE ASSOCIATES INC /MD/ 0.75% 421,612 -3.8% 0% $1,046,000
GEODE CAPITAL MANAGEMENT, LLC 0.69% 386,799 +28% 0% $959,585
RENAISSANCE TECHNOLOGIES LLC 0.68% 380,508 +125% 0% $943,660
MILLENNIUM MANAGEMENT LLC 0.66% 373,987 -8.7% 0% $927,488
DAFNA Capital Management LLC 0.65% 363,636 0.22% $901,817
Knott David M Jr 0.35% 195,000 +95% 0.2% $483,600
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.32% 180,439 +30% 0% $447,489
AMH Equity Ltd 0.29% 166,000 0.52% $411,680
NORTHERN TRUST CORP 0.18% 102,572 +2.1% 0% $254,379
STATE STREET CORP 0.18% 100,733 -23% 0% $249,818
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.17% 98,105 -17% 0% $243,300
TD Asset Management Inc 0.16% 92,678 0% 0% $229,841
IFP Advisors, Inc 0.15% 86,698 +1.6% 0.01% $215,011
Cubist Systematic Strategies, LLC 0.14% 77,892 +340% 0% $193,172
JANE STREET GROUP, LLC 0.12% 65,524 +254% 0% $162,499
LASRY MARC 0.11% 60,869 0% 1% $150,955
CITADEL ADVISORS LLC 0.1% 54,002 +9.2% 0% $133,925

Institutional Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 51,595 $222,374 $4.31 1
2025 Q3 22,919,413 $56,168,029 +$11,822,203 $2.48 51
2025 Q2 17,679,478 $47,383,339 -$3,869,284 $2.68 57
2025 Q1 18,991,589 $81,285,627 -$1,022,773 $4.28 55
2024 Q4 19,199,487 $76,798,785 -$539,360 $4.00 52
2024 Q3 19,025,849 $97,783,259 +$23,796,820 $5.14 47
2024 Q2 14,216,993 $115,872,261 +$7,548,898 $8.15 46
2024 Q1 13,122,958 $69,159,471 +$81,607 $5.27 35
2023 Q4 13,269,980 $121,156,137 +$1,560,391 $9.13 39
2023 Q3 13,091,525 $114,161,215 +$20,426,958 $8.72 41
2023 Q2 10,783,562 $75,485,712 +$5,313,437 $7.00 39
2023 Q1 9,869,678 $193,150,702 +$179,532,879 $19.57 21
2022 Q4 685,801 $6,851,000 +$6,851,015 $9.99 1